Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;49:679-686
Published online before print December 4, 2006, doi: 10.1161/01.HYP.0000253085.56217.11
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
49/3/679    most recent
01.HYP.0000253085.56217.11v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Virdis, A.
Right arrow Articles by Del Tacca, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Virdis, A.
Right arrow Articles by Del Tacca, M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Animal models of human disease
Right arrow Hypertension - basic studies

(Hypertension. 2007;49:679.)
© 2007 American Heart Association, Inc.


Original Articles, Part 2

Cyclooxygenase-1 Is Involved in Endothelial Dysfunction of Mesenteric Small Arteries From Angiotensin II–Infused Mice

Agostino Virdis; Rocchina Colucci; Matteo Fornai; Emiliano Duranti; Chiara Giannarelli; Nunzia Bernardini; Cristina Segnani; Chiara Ippolito; Luca Antonioli; Corrado Blandizzi; Stefano Taddei; Antonio Salvetti; Mario Del Tacca

From the Department of Internal Medicine (A.V., R.C., M.F., E.D., C.G., L.A., C.B., S.T., A.S., M.D.T.), Department of Human Morphology and Applied Biology, Section of Histology and General Embryology (N.B., C.S., C.I.), University of Pisa, Pisa, Italy.

Correspondence to Agostino Virdis, Department of Internal Medicine, University of Pisa, Via Roma, 67, 56100 Pisa, Italy. E-mail a.virdis{at}med.unipi.it

Angiotensin II induces endothelial dysfunction by reducing NO availability and increasing reactive oxygen species. We assessed whether cyclooxygenase (COX)-1 or COX-2 participate in the angiotensin II–induced endothelial dysfunction in murine mesenteric small arteries and examined the role of reduced nicotinamide-adenine dinucleotide phosphate–dependent reactive oxygen species production. Mice received angiotensin II (600 ng/kg per minute, SC), saline (controls), angiotensin II + apocynin (reduced nicotinamide-adenine dinucleotide phosphate oxidase inhibitor, 2.5 mg/day), or apocynin alone for 2 weeks. Endothelial function of mesenteric arteries was assessed by pressurized myograph. In controls, acetylcholine-induced relaxation was inhibited by NG-monomethyl-L-arginine and unaffected by DFU (COX-2 inhibitor), SC-560 (COX-1 inhibitor), or ascorbic acid. In angiotensin II–infused animals, the attenuated response to acetylcholine was less sensitive to NG-monomethyl-L-arginine, unaffected by DFU, and enhanced by SC-560 and, similarly, by SQ-29548, a thromboxane–prostanoid receptor antagonist. Moreover, response to acetylcholine was unchanged by ozagrel, a thromboxane synthase inhibitor, and normalized by ascorbic acid. Apocynin prevented the angiotensin II–induced vascular dysfunctions. In angiotensin II–infused mice, RT-PCR analysis showed a significant COX-2 downregulation, whereas COX-1 expression was upregulated. These changes were unaffected by apocynin. Modulation of COX isoform by angiotensin II was also documented by immunohistochemistry. In small mesenteric vessels, the reduced NO availability and oxidant excess, which characterize endothelial dysfunction secondary to angiotensin II, are associated with a reduced COX-2 and an increased COX-1 function and expression. Angiotensin II causes an oxidative stress–independent COX-1 overexpression, whereas angiotensin II–mediated oxidant excess production stimulates COX-1 activity to produce a contracting prostanoid endowed with agonist activity on thromboxane–prostanoid receptors.


Key Words: angiotensin II • microcirculation, cyclooxygenase • endothelium • oxidative stress




This article has been cited by other articles:


Home page
HypertensionHome page
W. J. Welch
Angiotensin II-Dependent Superoxide: Effects on Hypertension and Vascular Dysfunction
Hypertension, July 1, 2008; 52(1): 51 - 56.
[Full Text] [PDF]


Home page
HypertensionHome page
S. Verlohren, M. Niehoff, L. Hering, N. Geusens, F. Herse, A. N. Tintu, A. Plagemann, F. LeNoble, R. Pijnenborg, D. N. Muller, et al.
Uterine Vascular Function in a Transgenic Preeclampsia Rat Model
Hypertension, February 1, 2008; 51(2): 547 - 553.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M.-E. Gendron and E. Thorin
A change in the redox environment and thromboxane A2 production precede endothelial dysfunction in mice
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2508 - H2515.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Matsumoto, M. Kakami, E. Noguchi, T. Kobayashi, and K. Kamata
Imbalance between endothelium-derived relaxing and contracting factors in mesenteric arteries from aged OLETF rats, a model of Type 2 diabetes
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1480 - H1490.
[Abstract] [Full Text] [PDF]